{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:29:15Z","timestamp":1789003755592,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.micpath.2021.104737","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T16:18:24Z","timestamp":1610554704000},"page":"104737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["PNA-mediated efflux inhibition as a therapeutic strategy towards overcoming drug resistance in Mycobacterium smegmatis"],"prefix":"10.1016","volume":"151","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1071-224X","authenticated-orcid":false,"given":"Saptarshi","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7158-7310","authenticated-orcid":false,"given":"Karishma Berta","family":"Cotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6397-3174","authenticated-orcid":false,"given":"Aniket A.","family":"Hande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moneesha","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3844-4726","authenticated-orcid":false,"given":"Sarika","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2021.104737_bib1","series-title":"Global Tuberculoisis Report 2019","first-page":"1","author":"Baddeley","year":"2019"},{"key":"10.1016\/j.micpath.2021.104737_bib2","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1128\/AAC.48.7.2415-2423.2004","article-title":"Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis","volume":"48","author":"Li","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104737_bib3","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1586\/eri.12.89","article-title":"Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs","volume":"10","author":"Viveiros","year":"2012","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.micpath.2021.104737_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-695X.2011.00831.x","article-title":"Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis","volume":"63","author":"da Silva","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.micpath.2021.104737_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1574-6976.2005.00002.x","article-title":"Role of mycobacterial efflux transporters in drug resistance: an unresolved question","volume":"30","author":"De Rossi","year":"2006","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.micpath.2021.104737_bib6","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1128\/AAC.01577-08","article-title":"A balancing act: efflux\/influx in mycobacterial drug resistance","volume":"53","author":"Louw","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.micpath.2021.104737_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119013","article-title":"Efflux pump gene expression in multidrug-resistant Mycobacterium tuberculosis clinical isolates","volume":"10","author":"Li","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2021.104737_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ja.2015.9","article-title":"Study of efflux pump gene expression in rifampicin-monoresistant Mycobacterium tuberculosis clinical isolates","volume":"68","author":"Li","year":"2015","journal-title":"J. Antibiot."},{"key":"10.1016\/j.micpath.2021.104737_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2011.02.022","article-title":"Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism","volume":"145","author":"Adams","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.micpath.2021.104737_bib10","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1164\/rccm.201304-0650OC","article-title":"Acceleration of tuberculosis treatment by adjunctive therapy with verapamil as an efflux inhibitor","volume":"188","author":"Gupta","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.micpath.2021.104737_bib11","doi-asserted-by":"crossref","unstructured":"Machado D, Couto, I., Perdigao, J., Rodrigues, L., Portugal, I., Baptista, P., Veigas, B., Amaral, L., Viveiros, M. Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis. PloS One 7:e34538.","DOI":"10.1371\/journal.pone.0034538"},{"key":"10.1016\/j.micpath.2021.104737_bib12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.meegid.2011.08.009","article-title":"Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex","volume":"12","author":"Rodrigues","year":"2012","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.micpath.2021.104737_bib13","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1128\/AAC.01462-13","article-title":"Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis","volume":"58","author":"Gupta","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104737_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4103\/0970-2113.217567","article-title":"Effect of efflux pump inhibitors on the susceptibility of Mycobacterium tuberculosis to isoniazid","volume":"34","author":"Jaiswal","year":"2017","journal-title":"Lung India"},{"key":"10.1016\/j.micpath.2021.104737_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jac\/dkv316","article-title":"Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy","volume":"71","author":"Pule","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2021.104737_bib16","first-page":"535","article-title":"Effect of efflux pump inhibitors on drug susceptibility of ofloxacin resistant Mycobacterium tuberculosis isolates","volume":"133","author":"Singh","year":"2011","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.micpath.2021.104737_bib17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/bja\/72.3.361","article-title":"Overdose of sustained-release verapamil","volume":"72","author":"Barrow","year":"1994","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.micpath.2021.104737_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/1752-1947-5-399","article-title":"Lipid rescue of massive verapamil overdose: a case report","volume":"5","author":"Liang","year":"2011","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.micpath.2021.104737_bib19","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3109\/15563650.2014.965827","article-title":"Treatment for calcium channel blocker poisoning: a systematic review","volume":"52","author":"St-Onge","year":"2014","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.micpath.2021.104737_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(00)00087-9","article-title":"Peptide nucleic acids: versatile tools for gene therapy strategies","volume":"15","author":"Dean","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.micpath.2021.104737_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0959-440X(99)80047-5","article-title":"Peptide nucleic acids as therapeutic agents","volume":"9","author":"Nielsen","year":"1999","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.micpath.2021.104737_bib22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1385\/MB:26:3:233","article-title":"PNA technology","volume":"26","author":"Nielsen","year":"2004","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.micpath.2021.104737_bib23","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1021\/acs.bioconjchem.6b00013","article-title":"Antibacterial peptide nucleic acid-antimicrobial peptide (PNA-AMP) conjugates: antisense targeting of fatty acid biosynthesis","volume":"27","author":"Hansen","year":"2016","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.micpath.2021.104737_bib24","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00253-009-2099-0","article-title":"Sequence-specific bacterial growth inhibition by peptide nucleic acid targeted to the mRNA binding site of 16S rRNA","volume":"84","author":"Hatamoto","year":"2009","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2021.104737_bib25","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1128\/AAC.00709-06","article-title":"Inhibition of gene expression and growth by antisense peptide nucleic acids in a multiresistant beta-lactamase-producing Klebsiella pneumoniae strain","volume":"51","author":"Kurupati","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104737_bib26","doi-asserted-by":"crossref","first-page":"103907","DOI":"10.1016\/j.micpath.2019.103907","article-title":"Antisense peptide nucleic acids against ftsZ and efaA genes inhibit growth and biofilm formation of Enterococcus faecalis","volume":"139","author":"Narenji","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2021.104737_bib27","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.1128\/AAC.01437-12","article-title":"Targeting essential genes in Salmonella enterica serovar typhimurium with antisense peptide nucleic acid","volume":"56","author":"Soofi","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104737_bib28","doi-asserted-by":"crossref","first-page":"103646","DOI":"10.1016\/j.micpath.2019.103646","article-title":"Peptide nucleic acid-mediated re-sensitization of colistin resistance Escherichia coli KP81 harboring mcr-1 plasmid","volume":"135","author":"Nezhadi","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2021.104737_bib29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nbt0498-332","article-title":"PNA, antisense, and antimicrobials","volume":"16","author":"Ecker","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.micpath.2021.104737_bib30","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/nat.2013.0426","article-title":"Targeting Listeria monocytogenes rpoA and rpoD genes using peptide nucleic acids","volume":"23","author":"Alajlouni","year":"2013","journal-title":"Nucleic Acid Therapeut."},{"key":"10.1016\/j.micpath.2021.104737_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029886","article-title":"Targeting RNA polymerase primary sigma70 as a therapeutic strategy against methicillin resistant Staphylococcus aureus by antisense peptide nucleic acid","volume":"7","author":"Bai","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2021.104737_bib32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12866-015-0599-x","article-title":"Oxacillin sensitization of methicillin resistant Staphylococcus aureus and methicillin-resistant Staphylococcus pseudintermedius by antisense peptide nucleic acids in vitro","volume":"15","author":"Goh","year":"2015","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.micpath.2021.104737_bib33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nbt0498-355","article-title":"Antisense inhibition of gene expression in bacteria by PNA targeted to mRNA","volume":"16","author":"Good","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.micpath.2021.104737_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2014.09.015","article-title":"Inhibiting the growth of methicillin-resistant Staphylococcus aureus in vitro with antisense peptide nucleic acid conjugates targeting the ftsZ gene","volume":"30","author":"Liang","year":"2015","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.micpath.2021.104737_bib35","series-title":"Securing New Drugs for Future Generations: the Pipeline of Antibiotics. The Review on Antimicrobial Resistance","author":"O'Neill","year":"2015"},{"key":"10.1016\/j.micpath.2021.104737_bib36","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1128\/jb.178.13.3791-3795.1996","article-title":"Active efflux of fluoroquinolones in Mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump","volume":"178","author":"Liu","year":"1996","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2021.104737_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1574-6968.2000.tb09396.x","article-title":"Contribution of the multidrug efflux pump LfrA to innate mycobacterial drug resistance","volume":"193","author":"Sander","year":"2000","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.micpath.2021.104737_bib38","series-title":"Nanoparticles to Enhance Efficacy of Antibiotics by Overcoming Intrinsic and Acquired Drug Resistance in Mycobacterium Smegmatis","author":"Padwal","year":"2015"},{"key":"10.1016\/j.micpath.2021.104737_bib39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2180-11-35","article-title":"Ethidium bromide transport across Mycobacterium smegmatis cell-wall: correlation with antibiotic resistance","volume":"11","author":"Rodrigues","year":"2011","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.micpath.2021.104737_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0167-7012(00)00241-4","article-title":"How to optimize the drop plate method for enumerating bacteria","volume":"44","author":"Herigstad","year":"2001","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.micpath.2021.104737_bib41","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/86753","article-title":"Bactericidal antisense effects of peptide-PNA conjugates","volume":"19","author":"Good","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.micpath.2021.104737_bib42","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1128\/AAC.47.7.2118-2124.2003","article-title":"Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis","volume":"47","author":"Jayaram","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2021.104737_bib43","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1128\/CVI.00446-09","article-title":"Validation of a medium-throughput method for evaluation of intracellular growth of Mycobacterium tuberculosis","volume":"17","author":"Eklund","year":"2010","journal-title":"Clin. Vaccine Immunol. : CVI"},{"key":"10.1016\/j.micpath.2021.104737_bib44","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00232-017-9982-x","article-title":"Mycobacterium tuberculosis major facilitator superfamily transporters","volume":"250","author":"Li","year":"2017","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.micpath.2021.104737_bib45","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1089\/154545703322860753","article-title":"The translation start codon region is sensitive to antisense PNA inhibition in Escherichia coli","volume":"13","author":"Dryselius","year":"2003","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.micpath.2021.104737_bib46","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.1074\/jbc.M106624200","article-title":"Cell permeabilization and uptake of antisense peptide-peptide nucleic acid (PNA) into Escherichia coli","volume":"277","author":"Eriksson","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2021.104737_bib47","article-title":"AdeB efflux pump gene knockdown by mRNA mediated peptide nucleic acid in multidrug resistance Acinetobacter baumannii","volume":"139","author":"Abdi","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2021.104737_bib48","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/nat.2012.0370","article-title":"Potent antibacterial antisense peptide-peptide nucleic acid conjugates against Pseudomonas aeruginosa","volume":"22","author":"Ghosal","year":"2012","journal-title":"Nucleic Acid Therapeut."},{"key":"10.1016\/j.micpath.2021.104737_bib49","first-page":"101","article-title":"Inhibition of Mycobacterium smegmatis gene expression and growth using antisense peptide nucleic acids","volume":"9","author":"Kulyte","year":"2005","journal-title":"J. Mol. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2021.104737_bib50","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/jac\/dkt381","article-title":"Target optimization for peptide nucleic acid (PNA)-mediated antisense inhibition of the CmeABC multidrug efflux pump in Campylobacter jejuni","volume":"69","author":"Oh","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2021.104737_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102135","article-title":"Acquired resistance of Mycobacterium tuberculosis to bedaquiline","volume":"9","author":"Andries","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2021.104737_bib52","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3389\/fmicb.2017.00711","article-title":"Interplay between mutations and efflux in drug resistant clinical isolates of Mycobacterium tuberculosis","volume":"8","author":"Machado","year":"2017","journal-title":"Front. Microbiol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021000097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401021000097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:32:07Z","timestamp":1760110327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401021000097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":52,"alternative-id":["S0882401021000097"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2021.104737","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PNA-mediated efflux inhibition as a therapeutic strategy towards overcoming drug resistance in Mycobacterium smegmatis","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2021.104737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104737"}}